Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Harvard Apparatus Regenerative Technology, Inc.

OTC: HRGN · Industrial Applications and Services · 3 alerts · CIK 1563665

Share price
$1.90Close, Nov 16
Market cap
$38.2M
Shares outstanding
20.09MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Harvard Apparatus Regenerative Technology, Inc. filings on SEC EDGAR ↗

11:22 AM ET 10-Q
Financial Results

Harvard Apparatus Regenerative Technology Q3 2026 Results: Net Loss of $1.46M, Loss Narrows

For the nine months ended September 30, 2026, Harvard Apparatus Regenerative Technology reported a net loss of $4.8 million, a slight improvement from the $5.2 million loss in the prior year period. While product revenue increased to $785,000, the company continues to operate with a significant accumulated deficit of $111.3 million and highlights its dependence on future capital raises to continue as a going concern.

Key figure
Net loss $1.46M
10:52 AM ET Form 4
Insider Buying

Harvard Apparatus Regenerative Technology CEO Junli He Buys $394K of Stock

Junli He, CEO, bought 368,630 shares of Harvard Apparatus Regenerative Technology, Inc. at $1.05 to $2.15 a share (average $1.07) in 2 transactions, worth $394K in total between Sep 11, 2026 and Sep 15, 2026. Shares held after the trade: 1,332,930 (+0.5%).

Value
$394K
Shares
368,630
Average price
$1.07
Role
CEO
Holding change
+0.5%
Trade date
Sep 11, 2026 to Sep 15, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.